These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21452975)

  • 1. Obama budget aims to lower biologics exclusivity period.
    Future Med Chem; 2011 Mar; 3(4):395. PubMed ID: 21452975
    [No Abstract]   [Full Text] [Related]  

  • 2. Congress works to permit 'biosimilar' drugs very soon.
    Carroll J
    Manag Care; 2009 Apr; 18(4):7-8. PubMed ID: 19472559
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law.
    Dinh TQ
    Food Drug Law J; 2007; 62(1):77-137. PubMed ID: 17444027
    [No Abstract]   [Full Text] [Related]  

  • 4. Brand biologics grab 12 years' exclusivity, for now.
    Osborne R
    Nat Biotechnol; 2009 Aug; 27(8):677-8. PubMed ID: 19668153
    [No Abstract]   [Full Text] [Related]  

  • 5. US biotech prepares to fight generic biologics.
    Reid B
    Nat Biotechnol; 2002 Apr; 20(4):322. PubMed ID: 11923820
    [No Abstract]   [Full Text] [Related]  

  • 6. Blockbusters for cheap? The difficulties surrounding generic biologics.
    Josephson SA; Johnston SC; Hauser SL
    Ann Neurol; 2013 Sep; 74(3):A7-8. PubMed ID: 24115256
    [No Abstract]   [Full Text] [Related]  

  • 7. Data exclusivity for biologics.
    Grabowski H; Long G; Mortimer R
    Nat Rev Drug Discov; 2011 Jan; 10(1):15-6. PubMed ID: 21193860
    [No Abstract]   [Full Text] [Related]  

  • 8. Biosimilars and innovation: an analysis of the possibility of increased competition in biopharmaceuticals.
    Blackstone EA; Fuhr JP
    Future Med Chem; 2010 Nov; 2(11):1641-9. PubMed ID: 21428836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SuperGenerics: a better alternative for biogenerics.
    Charles SA
    Drug Discov Today; 2005 Apr; 10(8):533-5. PubMed ID: 15837591
    [No Abstract]   [Full Text] [Related]  

  • 10. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 1.
    Kuhrt K; Chace-Ortiz M
    IDrugs; 2009 Dec; 12(12):760-4. PubMed ID: 19943217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Biosimilar' drugs poised to penetrate market.
    Ledford H
    Nature; 2010 Nov; 468(7320):18-9. PubMed ID: 21048737
    [No Abstract]   [Full Text] [Related]  

  • 12. Market watch: Sales of biologics to show robust growth through to 2013.
    Goodman M
    Nat Rev Drug Discov; 2009 Nov; 8(11):837. PubMed ID: 19876035
    [No Abstract]   [Full Text] [Related]  

  • 13. Balancing innovation, access, and profits--market exclusivity for biologics.
    Engelberg AB; Kesselheim AS; Avorn J
    N Engl J Med; 2009 Nov; 361(20):1917-9. PubMed ID: 19828525
    [No Abstract]   [Full Text] [Related]  

  • 14. Market exclusivity for biologics.
    Wheadon DE
    N Engl J Med; 2010 Feb; 362(7):661; author reply 661-2. PubMed ID: 20164494
    [No Abstract]   [Full Text] [Related]  

  • 15. Takings issues in the approval of generic biologics.
    Yoo JC
    Food Drug Law J; 2005; 60(1):33-43. PubMed ID: 15940853
    [No Abstract]   [Full Text] [Related]  

  • 16. Exclusivity strategies and opportunities in view of the Biologics Price Competition and Innovation Act.
    Gaudry KS
    Food Drug Law J; 2011; 66(4):587-630, ii. PubMed ID: 24505830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress and Hurdles for Follow-on Biologics.
    Sarpatwari A; Avorn J; Kesselheim AS
    N Engl J Med; 2015 Jun; 372(25):2380-2. PubMed ID: 25946143
    [No Abstract]   [Full Text] [Related]  

  • 18. Democrats prioritize pricing, generics and drug safety.
    Fox JL
    Nat Biotechnol; 2007 Feb; 25(2):150-1. PubMed ID: 17287735
    [No Abstract]   [Full Text] [Related]  

  • 19. Biosimilars legislation awakens data exclusivity debate.
    Hutson S
    Nat Med; 2009 Nov; 15(11):1242. PubMed ID: 19893548
    [No Abstract]   [Full Text] [Related]  

  • 20. Epo, by any other name.
    Nature; 2007 Sep; 449(7160):259. PubMed ID: 17882170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.